Mark Dybul

Mark Dybul

Chief Executive Officer bei RENOVARO INC.

Vermögen: 176 175 $ am 31.03.2024

60 Jahre
Commercial Services
Health Technology
Health Services

Profil

Mark Richard Dybul is currently the Executive Vice Chairman & Chief Executive Officer at Renovaro, Inc. He is also the Director at the Elton John AIDS Foundation, Inc., the International AIDS Vaccine Initiative, Inc., and the Elton John AIDS Foundation.
Additionally, he serves as the Faculty Co-Director & Professor at Georgetown University Medical Center and as a Director at Big Win Philanthropy and the National Academy of Medicine.
In the past, Dr. Dybul has worked as the Director of the Elizabeth Glaser Pediatric AIDS Foundation, the Executive Director of Management Sciences for Health, Inc., and the Executive Director of The Global Fund to Fight AIDS, Tuberculosis & Malaria.
He has also held positions as the Director of the National Institute of Allergy & Infectious Diseases, the Director of the Catholic Medical Mission Board, Inc., and the Director & Chief Medical Officer of the United States President's Emergency Plan for AIDS Relief.
Additionally, he served as the Co-Director-Global Health Law Program at the O'Neill Institute For National & Global Health Law.
Dr. Dybul obtained his undergraduate degree from Georgetown University School of Medicine.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
13.02.2024 66 481 ( 0,05% ) 176 175 $ 31.03.2024

Aktive Positionen von Mark Dybul

UnternehmenPositionBeginn
RENOVARO INC. Chief Executive Officer 20.07.2021
Georgetown University Medical Center Corporate Officer/Principal 01.06.2017
Director/Board Member -
Director/Board Member -
Director/Board Member -
National Academy of Medicine Corporate Officer/Principal -
Director/Board Member -
Alle aktiven Positionen von Mark Dybul

Ehemalige bekannte Positionen von Mark Dybul

UnternehmenPositionEnde
The Global Fund to Fight AIDS, Tuberculosis & Malaria Director/Board Member 01.05.2017
O'Neill Institute For National & Global Health Law Director/Board Member 01.01.2012
░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░ ░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Sehen Sie sich die Erfahrung von Mark Dybul im Detail an

Ausbildung von Mark Dybul

Georgetown University School of Medicine Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Mark Dybul im Detail an

Beziehungen

99

Beziehungen ersten Grades

15

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen1
RENOVARO INC.

Health Technology

Private Unternehmen12

Commercial Services

Commercial Services

Health Technology

Health Services

The Global Fund to Fight AIDS, Tuberculosis & Malaria

Commercial Services

National Institute of Allergy & Infectious Diseases

Government

Commercial Services

National Academy of Medicine

Commercial Services

Health Services

Commercial Services

O'Neill Institute For National & Global Health Law

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Mark Dybul